Zacks Research upgraded shares of Lifevantage (NASDAQ:LFVN – Free Report) from a strong sell rating to a hold rating in a research note issued to investors on Monday,Zacks reports.
LFVN has been the topic of several other research reports. Freedom Broker dropped their target price on shares of Lifevantage from $9.00 to $8.00 and set a “buy” rating on the stock in a research report on Friday, November 13th. Lake Street Capital upped their target price on Lifevantage from $5.00 to $6.00 and gave the company a “hold” rating in a report on Friday, August 28th. Weiss Ratings downgraded Lifevantage from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday. Finally, UBS Group set a $8.00 price target on Lifevantage in a research report on Friday. One investment analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $6.75.
Check Out Our Latest Stock Report on Lifevantage
Lifevantage Trading Up 0.2%
Shares of Lifevantage stock opened at $4.78 on Monday. The company has a market capitalization of $60.61 million, a P/E ratio of 22.76 and a beta of 0.71. The stock has a fifty day simple moving average of $5.87 and a 200 day simple moving average of $5.85. Lifevantage has a 12-month low of $3.90 and a 12-month high of $11.71.
Lifevantage (NASDAQ:LFVN – Get Free Report) last released its quarterly earnings results on Monday, November 9th. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.06 by ($0.01). Lifevantage had a return on equity of 16.35% and a net margin of 1.58%. The firm had revenue of $37.12 million for the quarter, compared to analysts’ expectations of $40.49 million.
Lifevantage Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Tuesday, December 1st will be issued a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a yield of 4.2%. The ex-dividend date is Tuesday, December 1st. Lifevantage’s dividend payout ratio (DPR) is 95.24%.
Insider Buying and Selling
In related news, insider Kristen Cunningham sold 8,901 shares of Lifevantage stock in a transaction that occurred on Monday, September 14th. The shares were sold at an average price of $6.18, for a total value of $55,008.18. Following the sale, the insider owned 120,162 shares of the company’s stock, valued at approximately $742,601.16. The trade was a 6.90% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Michael A. Beindorff sold 10,000 shares of the company’s stock in a transaction that occurred on Thursday, November 12th. The shares were sold at an average price of $4.89, for a total value of $48,900.00. Following the completion of the transaction, the director owned 31,625 shares in the company, valued at approximately $154,646.25. The trade was a 24.02% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 19,001 shares of company stock valued at $104,549 over the last three months. Insiders own 13.58% of the company’s stock.
Institutional Trading of Lifevantage
Large investors have recently bought and sold shares of the company. Bank of New York Mellon Corp boosted its position in shares of Lifevantage by 11.9% during the first quarter. Bank of New York Mellon Corp now owns 33,547 shares of the company’s stock valued at $145,000 after buying an additional 3,571 shares during the last quarter. Bank of America Corp DE raised its position in Lifevantage by 24.3% in the 1st quarter. Bank of America Corp DE now owns 23,445 shares of the company’s stock worth $101,000 after buying an additional 4,586 shares during the last quarter. Hsbc Holdings PLC purchased a new position in Lifevantage in the 1st quarter worth about $51,000. Finally, Engineers Gate Manager LP lifted its stake in Lifevantage by 109.7% during the 2nd quarter. Engineers Gate Manager LP now owns 27,009 shares of the company’s stock valued at $169,000 after acquiring an additional 14,131 shares during the period. 35.32% of the stock is owned by hedge funds and other institutional investors.
About Lifevantage
LifeVantage Corporation is a health and wellness company that develops and sells dietary supplements, skincare products and other wellness offerings. Its product range includes Protandim supplements and the TrueScience skincare line, with products marketed around the company’s focus on nutrigenomics—the study of how nutrition interacts with gene expression. Founded in 2003, LifeVantage primarily sells through independent consultants and online channels. The company serves customers in markets across North America, Europe and the Asia-Pacific region.
Further Reading
- Five stocks we like better than Lifevantage
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
Receive News & Ratings for Lifevantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lifevantage and related companies with MarketBeat.com's FREE daily email newsletter.
